Form D · Pharmaceuticals
Altesa BioSciences, Inc.
College Park, GA · CIK 0001960618
Offering snapshot reported Feb 23, 2026 · SEC filing
- Reported sold
- $75M Offering amount: $75M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2026 | Initial | $74,999,986 | No comparison | 17 | SEC filing |
| Jul 7, 2023 | Amendment | $35,000,000 | $20,135,027vs Jan 5, 2023 | 18 | SEC filing |
| Jan 5, 2023 | Initial | $14,864,973 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-574317
Source: Form D, filed Feb 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Clerici | Executive |
| Andrew Drechsler | Executive |
| Jon Edwards | Director |
| Brett Giroir | Director, Executive |
| Ittai Harel | Director |
| Seth Rudnick | Director |
| Moncef Slaoui | Director |
| Nicholas Williams | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1930 Harvard Avenue
College Park, GA, 30337
Phone: 703-795-4274
College Park, GA, 30337
Phone: 703-795-4274